Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1978 Jul;62(1):119–123. doi: 10.1172/JCI109095

Increased glycosphingolipid excretion associated with proteinuria.

R R Townsend, R M Orth, C M Clawson, S C Li, Y T Li
PMCID: PMC371744  PMID: 96141

Abstract

The urine of patients with proteinuria of various etiologies was examined to determine if proteinuria alone was associated with significant glycosphingolipiduria. In all cases of proteinuria examined, the level of glycosphingolipids in the urine was found to be markedly elevated. There was no evidence of a glycosphingolipid storage disorder in any case. It was concluded that significant glycosphingolipiduria may occur in proteinuria as well as in the glycosphingolipid storage disorders.

Full text

PDF
119

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avila J. L., Convit J., Velazquez-Avila G. Fabry's disease: normal alpha-galactosidase activity and urinary-sediment glycosphingolipid levels in two obligate heterozygotes. Br J Dermatol. 1973 Aug;89(2):149–157. doi: 10.1111/j.1365-2133.1973.tb02951.x. [DOI] [PubMed] [Google Scholar]
  2. Brady R. O. Enzyme defects in the sphingolipidoses and their application to diagnosis. Ann Clin Lab Sci. 1972 Jul-Aug;2(4):285–294. [PubMed] [Google Scholar]
  3. Brady R. O. The adnormal biochemistry of inherited disorders of lipid metabolism. Fed Proc. 1973 Jun;32(6):1660–1667. [PubMed] [Google Scholar]
  4. Clarke J. T., Knaack J., Crawhall J. C., Wolfe L. S. Ceramide trihexosidosis (fabry's disease) without skin lesions. N Engl J Med. 1971 Feb 4;284(5):233–235. doi: 10.1056/NEJM197102042840503. [DOI] [PubMed] [Google Scholar]
  5. Desnick R. J., Dawson G., Desnick S. J., Sweeley C. C., Krivit W. Diagnosis of glycosphingolipidoses by urinary-sediment analysis. N Engl J Med. 1971 Apr 8;284(14):739–744. doi: 10.1056/NEJM197104082841401. [DOI] [PubMed] [Google Scholar]
  6. Desnick R. J., Sweeley C. C., Krivit W. A method for the quantitative determination of neutral glycosphingolipids in urine sediment. J Lipid Res. 1970 Jan;11(1):31–37. [PubMed] [Google Scholar]
  7. Goto I., Tabira T., Nawa A., Kurokawa T., Kuroiwa Y. Biochemical and genetic studies in two families with Fabry disease. Arch Neurol. 1974 Jul;31(1):45–50. doi: 10.1001/archneur.1974.00490370071011. [DOI] [PubMed] [Google Scholar]
  8. Hakomori S. I., Siddiqui B., Li Y. T., Li S. C., Hellerqvist C. G. Anomeric structure of globoside and ceramide grihexoside of human erythrocytes and hamster fibroblasts. J Biol Chem. 1971 Apr 10;246(7):2271–2277. [PubMed] [Google Scholar]
  9. Kean E. L. Separation of gluco- and galactocerebrosides by means of borate thin-layer chromatography. J Lipid Res. 1966 May;7(3):449–452. [PubMed] [Google Scholar]
  10. Ledeen R. W., Yu R. K., Eng L. F. Gangliosides of human myelin: sialosylgalactosylceramide (G7) as a major component. J Neurochem. 1973 Oct;21(4):829–839. doi: 10.1111/j.1471-4159.1973.tb07527.x. [DOI] [PubMed] [Google Scholar]
  11. Li S. C., Li Y. T. Studies on the glycosidases of jack bean meal. 3. Crystallization and properties of beta-N-acetylhexosaminidase. J Biol Chem. 1970 Oct 10;245(19):5153–5160. [PubMed] [Google Scholar]
  12. Li S. C., Mazzotta M. Y., Chien S. F., Li Y. T. Isolation and characterization of jack bean beta-galactosidase. J Biol Chem. 1975 Sep 10;250(17):6786–6791. [PubMed] [Google Scholar]
  13. MAKITA A. BIOCHEMISTRY OF ORGAN GLYCOLIPIDS. II. ISOLATION OF HUMAN KIDNEY GLYCOLIPIDS. J Biochem. 1964 Mar;55:269–276. doi: 10.1093/oxfordjournals.jbchem.a127880. [DOI] [PubMed] [Google Scholar]
  14. Miras C. J., Mantzos J. D., Levis G. M. The isolation and partial characterization of glycolipids of normal human leucocytes. Biochem J. 1966 Mar;98(3):782–786. doi: 10.1042/bj0980782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mårtensson E. Neutral glycolipids of human kidney isolation, identification, and fatty acid composition. Biochim Biophys Acta. 1966 Apr 4;116(2):296–308. doi: 10.1016/0005-2760(66)90012-9. [DOI] [PubMed] [Google Scholar]
  16. Mårtensson E., Percy A., Svennerholm L. Kidney glycolipids in late infantile metachromatic leucodystrophy. Acta Paediatr Scand. 1966 Jan;55(1):1–9. doi: 10.1111/j.1651-2227.1966.tb15202.x. [DOI] [PubMed] [Google Scholar]
  17. Philippart M., Sarlieve L., Manacorda A. Urinary glycolipids in Fabry's disease. Their examination in the detection of atypical variants and the pre-symptomatic state. Pediatrics. 1969 Feb;43(2):201–206. [PubMed] [Google Scholar]
  18. Pilz H., Müller D., Linke I. Histochemical and biochemical studies of urinary lipids in metachromatic leukodystrophy and Fabry's disease. J Lab Clin Med. 1973 Jan;81(1):7–21. [PubMed] [Google Scholar]
  19. Svennerholm L., Månsson J. E., Li Y. T. Isolation and structural determination of a novel ganglioside, a disialosylpentahexosylceramide from human brain. J Biol Chem. 1973 Jan 25;248(2):740–742. [PubMed] [Google Scholar]
  20. Vance D. E., Sweeley C. C. Quantitative determination of the neutral glycosyl ceramides in human blood. J Lipid Res. 1967 Nov;8(6):621–630. [PubMed] [Google Scholar]
  21. Volk B. W., Schneck L., Clemmons J. E., Nicastri A. D. Fabry's disease in a black man without skin lesions. Neurology. 1974 Oct;24(10):991–995. doi: 10.1212/wnl.24.10.991. [DOI] [PubMed] [Google Scholar]
  22. Wenger D. A., Sattler M., Clark C., McKelvey H. An improved method for the identification of patients and carriers of Krabbe's disease. Clin Chim Acta. 1974 Oct 30;56(2):199–206. doi: 10.1016/0009-8981(74)90228-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES